# Basecamp Research raises $140 million for AI drug development

_Published Wednesday, September 23, 2026 at 5:22 PM EDT · Capital, AI · Latest · Tier 2 — Notable_

![Basecamp Research raises $140 million for AI drug development — Primary](https://images.siliconangle.com/blogs.dir/1/files/2026/09/Basecamp.png)

Basecamp Research announced a $140 million Series C funding round led by S32, with participation from investors including NATO and Nvidia. The company plans to use the capital to advance drug development and pursue more partnerships with pharmaceutical companies.

Basecamp's EDEN model is designed for medical research and was trained on its Trillion Gene Atlas, a dataset containing information on more than 100 billion genes. Its initial focus is developing cell therapies that alter a patient's cells inside the body. The company's account describes research and development plans, not a therapy brought to market.

## Sources

- [siliconangle.com](https://siliconangle.com/2026/09/23/ai-drug-discovery-startup-basecamp-research-raises-140m/)

---
Canonical: https://techandbusiness.org/newswire/BzD0BKD4XhRs_N8qfTRxGF
Published: 2026-09-23T21:22:07.144Z
Story chronology: 2026-09-23T20:42:05.000Z
Retrieved: 2026-09-23T22:50:07.612Z
Publisher: Tech & Business (techandbusiness.org)